Voltar
Artigo
BIBTEX RIS

A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition

2003; Springer Science+Business Media; Volume: 110; Issue: 11 Linguagem: Inglês

10.1007/s00702-003-0042-6

ISSN

1435-1463

Autores

Anthony Clarke, E S Johnson, Nicholas Mallard, T. H. Corn, A. E. Johnston, Malcolm Boyce, Steve Warrington, Douglas G MacMahon,

Tópico(s)

Autism Spectrum Disorder Research

Referência(s)